Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas

Modern Pathology

Volumn 24, Issue 11, 2011, Pages 1451-1461

  Asioli, Sofia ^a   Righi, Alberto ^a   De Biase, Dario ^b   Morandi, Luca ^b   Caliendo, Virginia ^c   Picciotto, Franco ^d   MacRipò, Giuseppe ^c   Maletta, Francesca ^a   Di Cantogno, Ludovica Verdun ^a   Chiusa, Luigi ^a   Eusebi, Vincenzo ^b   Bussolati, Gianni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c San Giovanni Battista San Lazzaro Hospital   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

FISH; Merkel cell carcinoma; p63 isoforms; prognosis; stage

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P63; VIRUS DNA;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; OVERALL SURVIVAL; POLYOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TP63 GENE;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYOMAVIRUS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 80455164685     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.100     Document Type: Article

References (25)

1. Kohler S, Kerl H. Merkel cell carcinoma. In: LeBoit E, Burg G, Weedon D, Sarasin A (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumors. IARC Press: Lyon, 2006, pp 272-273.
2. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100. (Pubitemid 351300792)
3. The Rockwell Merkel Cell Carcinoma Group. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 2009;27:4021-4026.
4. Lemos BD, Storer BE, Iyer JC, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751-761.
5. Asioli S, Righi A, Volante M, et al. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007;110:640-647. (Pubitemid 47106154)
6. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-713. (Pubitemid 29197649)
7. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718. (Pubitemid 29197650)
8. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transacti-vating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316. (Pubitemid 128379271)
9. de Biase D, Morandi L, Degli Esposti R, et al. p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions. Virchows Arch 2010;456:395-401.
10. Foschini MP, Gaiba A, Cocchi R, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004;444:332-339. (Pubitemid 38553637)
11. Rao P, Balzer BL, Lemos BD, et al. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med 2010;134:341-344.
12. Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histo-pathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 2010;23:824-833.
13. Duncavage EJ, Zehnbauer BA, Pfeifer JD. Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol 2009;22:516-521.
14. Lambros MB, Simpson PT, Jones C, et al. Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest 2006;86:398-408.
15. Castellano I, Sapino A, Arisio R, et al. Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases. Oncol Rep 2008;19:1271-1275.
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
17. Cox D. Regressions models and life table. JR Stat Soc 1972;34:187-220.
18. Allen PJ, Browne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23: 2300-2309. (Pubitemid 46218722)
19. Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008;68: 5009-5013.
20. Garneski KM, Warcola AH, Feng Q, et al. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumours. J Invest Dermatol 2009;129:246-248.
21. Becker JC, Houben R, Ugurel S. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009;129: 248-250.
22. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumour-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008;105: 16272-16277.
23. Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010;7:509-515.
24. Klein WM, Wu BP, Zhao S, et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102-107. (Pubitemid 44967955)
25. Abbas O, Richards JE, Yaar R, et al. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions. Mod Pathol 2011;24:90-97.